The Middle East foot and ankle devices market size was estimated at USD 198.53 million in 2025 and is projected to reach USD 337.86 million by 2033, growing at a CAGR of 6.92% from 2026 to 2033. The Middle East is experiencing a steadily increasing burden of degenerative joint disease, and osteoarthritis has emerged as one of the most significant contributors to long-term musculoskeletal impairment in the region.
According to a ResearchGate GmbH article published in October 2025, recent epidemiological estimates indicate that the age-standardized prevalence of osteoarthritis has reached 5,342.8 cases per 100,000 population, reflecting the widespread chronic joint degeneration that has become prevalent across Middle Eastern countries. Osteoarthritis progresses, and weight-bearing joints, such as the ankle and mid-foot, are frequently affected, causing loss of mobility, pain, and instability. This rising disease burden is driving higher demand for F&A interventions ranging from joint preservation and reconstruction to orthotic support and implant-based treatments, ultimately accelerating the use of fixation devices, arthrodesis hardware, and rehabilitation products across the Middle East.
The increasing prevalence of musculoskeletal disorders largely drives the demand for devices in the Middle East. According to a Saudi Medical Journal article published in May 2024, a recent study highlights the substantial burden of musculoskeletal disorders in clinical practice. Among 11,243 patients referred for physical therapy between 2021 and 2023, 37% were diagnosed with musculoskeletal conditions, with the lower limbs significantly affected. Especially, the F&A accounted for approximately 15% of cases, underscoring the high prevalence of disorders in weight-bearing joints. This trend underscores the growing clinical need for specialized F&A interventions, including reconstructive procedures, stabilization devices, orthotic supports, and rehabilitation solutions. The data reflect an increasing demand for F&A devices across the region, driven by both degenerative conditions and trauma-related musculoskeletal impairments.
The rising burden of diabetic foot ulcers and amputations drives market growth. According to the NCBI article published in March 2025, a recent meta-analysis reviewing 17 studies in diabetes patients, 20 in diabetic foot ulcer (DFU) patients, and two in both, found that the overall pooled amputation rate among all diabetes patients is 2% (95% CI: 1%-3%), while the pooled amputation rate among DFU patients is substantially higher at 33% (range: 24%-43%). Saudi Arabia reported rates notably higher than those of other countries in the region, highlighting disparities in preventive care, patient awareness, and early intervention. These findings indicate a high clinical need for surgical implants, reconstructive devices, orthotic supports, and post-operative rehabilitation solutions to manage DFU complications and prevent amputations. Given the rising prevalence of diabetes and recurrent foot ulcers in the Middle East, demand for specialized F&A devices is expected to grow significantly, particularly in countries with higher DFU-related amputation rates.
Technological advancement drives the growth of the market. For instance, in August 2024, KFSHRC reported successful ankle-joint replacement surgeries in two patients using state-of-the-art artificial joints, along with advanced 3D imaging to precisely map joint anatomy before implantation. The use of 3D imaging has helped improve surgical precision, minimize tissue damage, shorten hospital stays, and enhance mobility outcomes. Moreover, in January 2025, HMC announced it had introduced total ankle replacement surgery in Qatar, performing TAR on multiple patients in December 2024. This marks a milestone for advanced F&A reconstructive surgery in the Gulf region, increasing access to prosthetic joints for patients with severe damage to their joints.
This product will be delivered within 1-3 business days.
According to a ResearchGate GmbH article published in October 2025, recent epidemiological estimates indicate that the age-standardized prevalence of osteoarthritis has reached 5,342.8 cases per 100,000 population, reflecting the widespread chronic joint degeneration that has become prevalent across Middle Eastern countries. Osteoarthritis progresses, and weight-bearing joints, such as the ankle and mid-foot, are frequently affected, causing loss of mobility, pain, and instability. This rising disease burden is driving higher demand for F&A interventions ranging from joint preservation and reconstruction to orthotic support and implant-based treatments, ultimately accelerating the use of fixation devices, arthrodesis hardware, and rehabilitation products across the Middle East.
The increasing prevalence of musculoskeletal disorders largely drives the demand for devices in the Middle East. According to a Saudi Medical Journal article published in May 2024, a recent study highlights the substantial burden of musculoskeletal disorders in clinical practice. Among 11,243 patients referred for physical therapy between 2021 and 2023, 37% were diagnosed with musculoskeletal conditions, with the lower limbs significantly affected. Especially, the F&A accounted for approximately 15% of cases, underscoring the high prevalence of disorders in weight-bearing joints. This trend underscores the growing clinical need for specialized F&A interventions, including reconstructive procedures, stabilization devices, orthotic supports, and rehabilitation solutions. The data reflect an increasing demand for F&A devices across the region, driven by both degenerative conditions and trauma-related musculoskeletal impairments.
The rising burden of diabetic foot ulcers and amputations drives market growth. According to the NCBI article published in March 2025, a recent meta-analysis reviewing 17 studies in diabetes patients, 20 in diabetic foot ulcer (DFU) patients, and two in both, found that the overall pooled amputation rate among all diabetes patients is 2% (95% CI: 1%-3%), while the pooled amputation rate among DFU patients is substantially higher at 33% (range: 24%-43%). Saudi Arabia reported rates notably higher than those of other countries in the region, highlighting disparities in preventive care, patient awareness, and early intervention. These findings indicate a high clinical need for surgical implants, reconstructive devices, orthotic supports, and post-operative rehabilitation solutions to manage DFU complications and prevent amputations. Given the rising prevalence of diabetes and recurrent foot ulcers in the Middle East, demand for specialized F&A devices is expected to grow significantly, particularly in countries with higher DFU-related amputation rates.
Technological advancement drives the growth of the market. For instance, in August 2024, KFSHRC reported successful ankle-joint replacement surgeries in two patients using state-of-the-art artificial joints, along with advanced 3D imaging to precisely map joint anatomy before implantation. The use of 3D imaging has helped improve surgical precision, minimize tissue damage, shorten hospital stays, and enhance mobility outcomes. Moreover, in January 2025, HMC announced it had introduced total ankle replacement surgery in Qatar, performing TAR on multiple patients in December 2024. This marks a milestone for advanced F&A reconstructive surgery in the Gulf region, increasing access to prosthetic joints for patients with severe damage to their joints.
Middle East Foot And Ankle Devices Market Report Segmentation
This report forecasts revenue growth at the regional and country level and provides an analysis of industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the foot and ankle devices market report based on product, end use, and region:- Product Outlook (Revenue USD Million, 2021-2033)
- Foot and Ankle (F&A) Trauma
- Foot & Ankle (F&A) Reconstruction
- Foot & Ankle (F&A) Orthobiologics
- Foot & Ankle (F&A) Soft Tissue Repair
- End Use Outlook (Revenue USD Million, 2021-2033)
- Hospitals
- Outpatient Facilities
- Country Outlook Revenue USD Million, 2021-2033)
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Middle East Foot and Ankle Devices Market Variables, Trends & Scope
Chapter 4. Middle East Foot and Ankle Devices Market Segment Analysis, By Product, 2021-2033 (USD Million)
Chapter 5. Middle East Foot and Ankle Devices Market Segment Analysis, By End Use, 2021-2033 (USD Million)
Chapter 6. Middle East Foot and Ankle Devices Market Segment Analysis, By Country, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this Middle East Foot and Ankle Devices market report include:- Stryker Corporation
- Johnson & Johnson (De PuySynthes)
- Zimmer Biomet
- Smith+Nephew
- Bioventus LLC
- Enovis Corp.
- Acumed LLC
- Arthrex, Inc.
- Globus Medical
- CONMED Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | January 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 198.53 Million |
| Forecasted Market Value ( USD | $ 337.86 Million |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Middle East |
| No. of Companies Mentioned | 11 |
